awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34062033-2E34DBF0-D010-4806-85EE-17D3207B08B3
Q34062033-2E34DBF0-D010-4806-85EE-17D3207B08B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34062033-2E34DBF0-D010-4806-85EE-17D3207B08B3
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma
P2860
Q34062033-2E34DBF0-D010-4806-85EE-17D3207B08B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34062033-2E34DBF0-D010-4806-85EE-17D3207B08B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ace4632583076bb96ad5fc8981d0741ac4919ef6
P2860
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.